Roadshow
VOCAL IMPLANT SYSTEM-APrevent® VOIS
APrevent VOIS is specifically designed for type I medialization thyroplasty procedure for treatment of unilateral vocal fold paralysis and/or glottic insufficiency. APrevent VOIS is the first thyroplasty implant offering intra- and post operative adjustment by injecting normal saline solution through an integrated port and expand the silicone balloon in specific vectors to compress the paralyzed vocal fold to the middle position and achieve complete glottic closure.
"Different sizes to fit different larynxes"
It comes in 4 sizes to overcome variations in laryngeal dimensions between individuals, different genders and ethnic groups.
"Standardized surgical procedure for localization and implantation"
We reinvented the exisiting type I medialization thyroplasty and standardized the surgical procedure by applying the APrevent VOIS instrument set. Follow suggected procedures in IFU and use the instrument to localize a 6*11 mm rectangualr window on thyroid cartilage so that operators could drill the window position precisely. By applying standardized procedures can reduce the operation time from 2 hours to only about 30 - 40 minutes minimizing revision rates, risks of airway complications, and providing patients with optimal results.
- Established 2014
- Company APrevent Medical Inc.
- Telephone +886-2-2888-1107
- Address 11141 7F, No.520, 5 sec, ZhongShan N. Rd., Shilin Dist., Taipei, Taiwan
APrevent is a medical device company, founded in 2013 by a team of international clinically experienced physicians and engineers. APrevent's products improve voice and communication, focusing on the development of a long- term implant system and speech conversion platform for patients with glottic insufficiency and dysarthria.
Our Vision
APrevent is dedicated to providing minimally invasive and innovative laryngeal implant and Software-as-a-Service (SaaS) technologies for voice & speech disorders, which are patient-orientated, physician friendly, and improve the quality of life for patients around the world.